TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/14/25 16:20 | 5/12/25 | ILMN | Illumina, Inc. | DE | Electr | LabEq | Laboratory Analytical Instrum | Dhingra Ankur | CA | O | SVP,CFO | P | 495 | 81.21 | 0 | 6 | 32 | 25 | D | ||||||||||||||
3/27/24 20:27 | 3/26/24 | SMMT | Summit Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Dhingra Ankur | CA | O | CFO | P | 375 | 3.75 | 0 | 100 | 39 | 355 | I | ||||||||||||||
12/13/23 16:49 | 12/13/23 | SMMT | Summit Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Dhingra Ankur | CA | O | CFO | P | 44 | 2.17 | 0 | 20 | 9 | 255 | I | ||||||||||||||
3/8/23 17:24 | 3/7/23 | SMMT | Summit Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Dhingra Ankur | CA | O | CFO | P | 206 | 1.05 | 0 | 196 | 253 | 274 | I | ||||||||||||||
3/8/23 16:58 | 8/16/22 | SMMT | Summit Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Dhingra Ankur | CA | O | CFO | P.a | 37 | 0.9700 | 0 | 38 | 94 | 78 | M |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |